*Asia one: "World's Greatest Leaders 2017-18"
*Asia one: "World's Greatest Brand 2017-18"
*The CEO Magazine: cover story June 2018 edition: “25 Most Trusted Healthcare Companies In India”
*9th Business Leaders’ Summit & Awards 2019: "Most Trusted Pharmaceutical Company In India 2019"
*Zee Business Presents National Healthcare Leadership Congress & Awards: "Innovative R&D Company of the year 2019"
The Management of SYNOKEM understands the value of ever changing technology, needs and TQM in all activates of a plant. We keep on updating ourselves in order to keep abreast ourselves with the new changes and adhering to new norms in PHARMA INDUSTRY always.
We have strong pipelines for other strengths of Ulipristal, which will be FIRST TIME IN INDIA.
SYNOKEM is the FIRST COMPANY to receive the DGCI for manufacturing of DIENOGEST TABLETS.
We are manufacturing for Top Companies like SUN, CIPLA, INTAS etc., etc.
Also, we have in pipeline of development for other combinations of DIENOGEST which will be manufactured FIRST TIME IN INDIA.
As SYNOKEM has entered into new arena i.e. INTERNATIONAL MARKETS, we are keep on changing and updating our facility as per requirement of stringent markets. The scope is really very vast and to overcome this challenge, the veteran people has been hired, new apparatus has been installed, and documents are being updated as per system requirements.
Uganda market in EA has got big potential, Synokem planned to get its self-audited from NDA after getting approved from PPB – Kenya.
We welcomed NDA audit team for inspection in the month of June 2017 and got our GMP certificate from NDA in September 2017. We have filed our dossiers with NDA and expecting approvals in first half of 2018.